Filing Flows › LivaNova (LIVN) › Q2 2026 › vs Q2 2025
LivaNova (LIVN) Q2 2026 vs Q2 2025 (year over year)
LivaNova's revenue rose $38.1M (+11%) from $353M in Q2 2025 to $391M in Q2 2026. Gross margin 70.1% against 67.8% (+2.3 pts).
LivaNova, Q2 2026: revenue $391M (+11% year over year), operating margin 12.7%, net earnings $109M, operating cash flow $66.6M. The chart draws each line against Q2 2025, the increases inside each band.
Margins
| Q2 2026 | Q2 2025 | Change | |
|---|---|---|---|
| Gross margin | 70.1% | 67.8% | +2.3 pts |
| Operating margin | 12.7% | 15.4% | -2.7 pts |
| Net margin | 27.8% | 7.7% | +20.1 pts |
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $391M | $353M | $38.1M | +11% |
| Gross profit | $274M | $239M | $34.7M | +15% |
| Cost of revenue | $117M | $114M | $3.4M | +3% |
| Operating profit | $49.5M | $54.2M | −$4.7M | -9% |
| Operating expenses | $224M | $185M | $39.4M | +21% |
| Pre-tax earnings | $18.5M | $33.3M | −$14.8M | -45% |
| Other expense, net | $31.0M | $20.9M | $10.1M | +49% |
| Research & development | $53.7M | $47.2M | $6.5M | +14% |
| SG&A | $158M | $138M | $20.3M | +15% |
| Income tax benefit | $90.2M | −$6.2M | $96.4M | — |
| Net earnings | $109M | $27.2M | $81.4M | +300% |
| Depreciation & amortization | $15.4M | $11.3M | $4.1M | +36% |
| Share-based compensation | $16.9M | $9.2M | $7.7M | +84% |
| Working capital & other | $74.3M | −$15.3M | $89.5M | — |
| Operating cash flow | $66.6M | $62.9M | $3.7M | +6% |
Questions
How much did LivaNova's revenue grow year over year in Q2 2026?
LivaNova's revenue rose $38.1M (+11%) from $353M in Q2 2025 to $391M in Q2 2026. Gross margin 70.1% against 67.8% (+2.3 pts).